KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Current Assets: 2009-2025

Historic Current Assets for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $974.6 million.

  • Novavax's Current Assets fell 11.70% to $974.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $974.6 million, marking a year-over-year decrease of 11.70%. This contributed to the annual value of $1.1 billion for FY2024, which is 1.31% down from last year.
  • Per Novavax's latest filing, its Current Assets stood at $974.6 million for Q3 2025, which was up 5.99% from $919.5 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Current Assets ranged from a high of $2.4 billion in Q2 2021 and a low of $727.1 million during Q1 2024.
  • Its 3-year average for Current Assets is $1.0 billion, with a median of $1.0 billion in 2023.
  • As far as peak fluctuations go, Novavax's Current Assets soared by 780.29% in 2021, and later plummeted by 58.63% in 2023.
  • Quarterly analysis of 5 years shows Novavax's Current Assets stood at $2.2 billion in 2021, then declined by 20.96% to $1.7 billion in 2022, then plummeted by 32.85% to $1.1 billion in 2023, then dropped by 1.31% to $1.1 billion in 2024, then decreased by 11.70% to $974.6 million in 2025.
  • Its last three reported values are $974.6 million in Q3 2025, $919.5 million for Q2 2025, and $868.0 million during Q1 2025.